Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures-Reference-Cited by-同舟云学术

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

Published:2012-07-24 Issue:2 Volume:135 Page:415-432
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Kabos Peter,Finlay-Schultz Jessica,Li Chunling,Kline Enos,Finlayson Christina,Wisell Joshua,Manuel Christopher A.,Edgerton Susan M.,Harrell J. Chuck,Elias Anthony,Sartorius Carol A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-012-2164-8.pdf

Reference64 articles.

1. Obiorah I, Jordan VC (2011) Progress in endocrine approaches to the treatment and prevention of breast cancer. Maturitas 70(4):315–321. doi: 10.1016/j.maturitas.2011.09.006

2. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21(10):1973–1979. doi: 10.1200/JCO.2003.09.099

3. Axlund SD, Sartorius CA (2012) Progesterone regulation of stem and progenitor cells in normal and malignant breast. Mol Cell Endocrinol 357(1–2):71–79. doi: 10.1016/j.mce.2011.09.021

4. Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H (2003) Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 98(4):703–711. doi: 10.1002/cncr.11532

5. Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Alvarez AC, Rodriguez JC, Lamelas ML, Vizoso FJ (2008) Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer 8:149. doi: 10.1186/1471-2407-8-149

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq;Journal of Genetic Engineering and Biotechnology;2023-12

2. Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast Cancer;Cell Cycle;2023-09-18

3. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer;Breast Cancer Research;2023-08-22

4. Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer;Cancers;2023-06-14

5. The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity;Frontiers in Oncology;2023-05-17